PCI Versus CABG: Comparative Effectiveness Study Funded By ARRA Grant
This article was originally published in The Gray Sheet
Executive Summary
The American College of Cardiology and Society of Thoracic Surgeons will study the comparative effectiveness of percutaneous coronary intervention and coronary artery bypass graft surgery with a $4 million NIH research grant, announced Oct. 2
You may also be interested in...
AHRQ, NIH Report To Congress On Comparative Effectiveness Spending Plans
Two Health and Human Services agencies will allocate about $250 million this year in comparative effectiveness research funds from the federal stimulus package; the remainder of the $1.1 billion comparative effectiveness money will be put to use in 2010
CABG Beats DES In SYNTAX Trial; Observers Expect Little Change In Practice
Analysts and physicians predict one-year results from the SYNTAX trial will have little short-term impact on demand for drug-eluting stents, even though the devices performed worse than coronary artery bypass graft (CABG) surgery in this seminal randomized trial
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.